 |
|
|
Forms 10-KSB
On this page you can find the annual reports of the company.
Our shareholders have entrusted us with approximately 13 million USD which have been invested in developing some of the most promising projects and products, some of which are currently on the brink of market entry.
Please note, however, that SanguiBiotech International, Inc., is a development company. Its main projects have not yet reached the clinical test phase. An investment in SanguiBiotech International, Inc., therefore, involves significant risks associated with economic, business, market and financial factors and developments which may have adverse impacts on the Company's future performance, including significant risks not normally associated with investing in equity securities of companies with proven market experience. It is recommended to carefully read Sangui's audited annual reports and other documents as filed with the SEC before taking an investment decision.
 |
07.04.2008
|
Annual Report
|
|
|
|
Period End 30.06.2006
|
|
|
18.06.2007
|
Annual Report
|
|
|
|
Period End 30.06.2005
|
|
|
28.02.2005
|
Annual Report
|
|
|
|
Period End 30.06.2004
|
|
|
27.09.2003
|
Annual Report
|
|
|
|
Period End 30.06.2003
|
|
|
27.09.2002
|
Annual Report
|
|
|
|
Period End 30.06.2002
|
|
|
29.10.2001
|
Annual Report (Amended)
|
|
|
|
Period End 30.06.2001
|
|
|
28.09.2001
|
Annual Report
|
|
|
|
Period End 30.06.2001
|
|
|
20.11.2000
|
Annual Report (Amended)
|
|
|
|
Period End 30.06.2000
|
|
|
13.10.2000
|
Annual Report
|
|
|
|
Period End 30.06.2000
|
|
|
|
|
|
